A R T I C L E S
Davis and Yang
equipped with a magnetic stirring bar and argon balloon was placed
1.28 g (5.41 mmol) of crude imine 23. Anhydrous benzene (120 mL)
and 2.06 g (10.8 mmol) of p-toluenesulfonic acid monohydrate were
added. After stirring for 40 h, the solution was concentrated, and the
residue was washed with saturated NaHCO3 solution. The solution was
next extracted with EtOAc (3 × 20 mL), and the combined organic
phases were dried (Na2SO4) and concentrated. Column chromatography
(10% EtOAc/hexane, 1% Et3N) afforded 0.74 g (58% from (-)-19) of
) 6.5, 1.4 Hz, 3 H), 1.82 (m, 1 H), 2.09 (ddd, J ) 4.7, 6.1, 9.0 Hz, 1
H), 2.20 (dt, J ) 3.5, 8.5 Hz, 1 H), 3.01 (dt, J ) 4.0, 8.5 Hz, 1 H),
3.26 (t, J ) 8.2 Hz, 1 H), 5.44 (m, 1 H), 5.59 (dq, J ) 6.5, 15.1 Hz,
1 H); 13C (CDCl3) NMR δ 12.0, 12.2, 14.0, 17.8, 19.3, 19.4, 23.7,
35.3, 54.3, 57.2, 57.5, 59.2, 128.1, 132.7, 213.7; HRMS calcd for
C15H27NO (M + H) 238.2171, found 238.2180.
(2S,3S,5R,6R)-(+)-3,5-Diethyl-2-((E)-prop-1-enyl)-6-propylpiperi-
din-4-one (26) from (+)-24. In a 50 mL, one-necked, round-bottomed
flask equipped with a magnetic stirring bar was placed 0.12 g of sodium
(previously washed with hexane), and anhydrous MeOH (6 mL) was
slowly added. The solution was stirred at room temperature for 1 h,
and 0.10 g of (+)-24 (0.42 mmol) was added. The solution was stirred
at 65 °C for 24 h and concentrated, and the residue was treated with
H2O (2 mL). The solution was extracted with EtOAc (3 × 3 mL), and
the combined organic phases were dried (Na2SO4) and concentrated.
Chromatography (10% EtOAc/hexane, 1% Et3N) afforded 0.055 g
(55%) of a colorless oil identical in all respects to (+)-26 prepared
previously (see above).
a colorless oil: [R]20 +54.8 (c 0.73, CHCl3); IR (neat) 3332, 2960,
D
1706 cm-1; 1H NMR δ (CDCl3) 0.79 (t, J ) 7.5 Hz, 3 H), 0.86 (t, J )
7.5 Hz, 3 H), 0.90 (t, J ) 7.5 Hz, 3 H), 1.23-1.35 (m, 4 H), 1.42 (m,
2 H), 1.59 (m, 2 H), 1.69 (dd, J ) 6.5, 1.7 Hz, 3 H), 1.82 (m, 1 H),
2.21 (m, 2 H), 2.86 (dt, J ) 3.2, 6.8 Hz, 1 H), 2.95 (dd, J ) 8.4, 10.3
Hz, 1 H), 5.42 (m, 1 H), 5.62 (dq, J ) 6.5, 15.1 Hz, 1 H); 13C NMR
(CDCl3) δ 11.4, 12.5, 14.2, 17.8, 18.11, 18.13, 19.4, 35.0, 53.7, 57.2,
59.5, 65.5, 128.8, 132.5, 213.9; HRMS calcd for C15H27NO (M + H)
238.2171, found 238.2170.
(2R,3S,5S,6R)-(+)-3,5-Diethyl-2-((E)-prop-1-enyl)-6-propylpiperi-
din-4-one (25). This compound was second to elute; 0.19 g (18% from
(2S,3S,5S,6R)-(+)-1-Allyl-3,5-diethyl-2-((E)-prop-1-enyl)-6-pro-
pylpiperidin-4-one (28). In a 100 mL, one-necked, round-bottomed
flask equipped with a magnetic stirring bar and condenser was placed
0.42 g (1.76 mmol) of (+)-24 in anhydrous EtOH (30 mL). To the
reaction mixture were added allyl bromide (1.53 mL) and anhydrous
solid Na2CO3 (2.8 g), and the reaction mixture was refluxed for 6 h.
At this time the solution was cooled to room temperature, filtered, and
concentrated. Water (10 mL) was added to the residue, and the solution
was extracted with dichloromethane (3 × 15 mL). The combined
organic phases were dried (Na2SO4) and concentrated. Chromatography
(-)-19) of a colorless oil: [R]20 +62.7 (c 1.31, CHCl3); IR (neat)
D
3336, 2960, 1705 cm-1; 1H NMR (CDCl3) δ 0.85-1.00 (m, 9 H), 1.20-
1.92 (m, 12 H), 2.47 (dt, J ) 5.3, 4.6 Hz, 1 H), 2.60 (dt, J ) 8.4, 5.8
Hz, 1 H), 3.31 (m, 1 H), 3.78 (d, J ) 5.5, 8.1 Hz, 1 H), 5.52 (m, 1 H),
5.67 (dq, J ) 15.2, 6.2 Hz, 1 H); 13C (CDCl3) NMR δ 11.70, 11.73,
14.1, 18.0, 18.4, 19.1, 19.2, 32.7, 54.2, 55.5, 55.6, 59.8, 128.4, 128.8,
214.6; HRMS calcd for C15H27NO (M + H) 238.2170, found 238.2181.
(2S,3S,5R,6R)-(+)-3,5-Diethyl-2-((E)-prop-1-enyl)-6-propylpiperi-
din-4-one (26). In a 100 mL, one-necked, round-bottomed flask
equipped with a magnetic stirring bar and argon balloon was placed
0.38 g (1.2 mmol) of (-)-18 in anhydrous methanol (20 mL). The
solution was cooled to 0 °C, and 0.36 mL of TFA (4.7 mmol) was
added via syringe. After warming to room temperature the reaction
mixture was stirred for 2 h, the solution was concentrated, and the
crude product was passed through a short silica gel pad eluting with
30% EtOAc/hexane to remove the p-toluenesulfinyl byproducts. Elution
with methanol gave the ammonium triflate salt, which was concentrated
and placed in a 100 mL, one-necked, round-bottomed flask equipped
with a magnetic stirring bar and argon balloon. Dichloromethane (20
mL) was added at room temperature followed by the addition of 0.46
mL (5.7 mmol) of crotonaldehyde via syringe. Anhydrous MgSO4, 1.5
g was added, and the reaction mixture was stirred at room temperature
for 2 h, concentrated, and washed with saturated NaHCO3 (15 mL).
The solution was extracted with EtOAc (3 × 10 mL), dried (Na2SO4),
and concentrated to give 0.26 g (93%) of the crude imine as a colorless
oil. In a separate 100 mL, one-necked, round-bottomed flask equipped
with a magnetic stirring bar and argon balloon was place the crude
imine, and anhydrous benzene (40 mL) was added, followed by 0.39
g (2.31 mmol) of p-toluenesulfonic acid monohydrate. After stirring
at room temperature for 40 h, the solvent was concentrated, the residue
was washed with saturated NaHCO3 (2 × 8 mL), and the organic phase
was extracted with EtOAc (3 × 8 mL). The combined organic phases
were dried (Na2SO4) and concentrated. Column chromatography (10%
EtOAx/hexane, 1% Et3N) afford 0.18 g (65%, from (-)-18) of a
colorless oil: [R]20D +19.4 (c 2.28, CHCl3); IR (neat) 3334, 2959, 1708
(6% EtOAc/hexane) afforded 0.44 g (91%) of a colorless oil: [R]20
D
+85.4 (c 0.56, CHCl3); IR (neat) 2961, 1715 cm-1; 1H NMR (CDCl3)
δ 0.81 (t, J ) 7.4 Hz, 3 H), 0.85 (t, J ) 7.5 Hz, 3 H), 0.87 (t, J ) 7.3
Hz, 3 H), 1.21-1.38 (m, 5 H), 1.53 (m, 1 H), 1.65 (m, 1 H), 1.72 (dd,
J ) 6.5, 1.5 Hz, 3 H), 1.86 (m, 1 H), 2.17 (ddd, J ) 4.0, 7.2, 10.0 Hz,
1 H), 2.47 (ddd, J ) 4.8, 5.8, 10.5 Hz, 1 H), 2.90 (m, 1 H), 3.18 (t, J
) 9.3, 1 H), 3.36 (m, 2 H), 5.11-5.24 (m, 3 H), 5.51 (dq, J ) 15.4,
6.5 Hz, 1 H), 5.84-5.92 (m, 1 H); 13C NMR (CDCl3) δ 11.1, 11.8,
14.4, 17.7, 18.7, 19.6, 20.6, 34.5, 52.7, 53.3, 54.5, 59.9, 65.3, 117.8,
128.2, 132.9, 134.3, 214.2; HRMS calcd for C18H31NO (M + H)
278.2484, found 278.2476.
(5R,6S,8S,8aS)-(+)-6,8-Diethylhexahydro-5-propylindolizin-7(1H)-
one (22) via RCM. In a 100 mL, one-necked, round-bottomed flask
equipped with a magnetic stirring bar and argon balloon were placed
0.22 g of (+)-28 and dichloromethane (30 mL). To the solution was
added 0.032 g (5 mol %) of the Grubbs “first generation” catalyst, and
the solution was refluxed for 2 h. At this time the solution was
concentrated, anhydrous methanol (20 mL) was added, followed by
0.050 g of 10% Pd/C, and the argon balloon was replaced by a
hydrogen-filled balloon. The reaction mixture was stirred at room
temperature for 4 h, the solution was filtered through a Celite pad, and
the pad was washed with methanol (3 × 10 mL). The solution was
concentrated, and the residue was purified by column chromatography
(1% Et3N, 15% EtOAc/hexane) to afford 0.135 g (71%) of a colorless
oil identical in all respects to (+)-22 prepared previously (see above).
(5R,6S,7S,8S,8aS)-(+)-6,8-Diethyloctahydro-5-propylindolizin-7-
ol (29). In a 50 mL, one-necked, round-bottomed flask equipped with
a magnetic stirring bar and argon balloon was placed 0.10 g (0.42 mmol)
of (+)-22 in anhydrous MeOH (20 mL). The solution was cooled to
-78 °C, and 0.024 g (0.63 mmol) of NaBH4 was added. After 2 h the
reaction mixture was warmed to room temperature and concentrated.
To the residue was added water (10 mL), the solution was extracted
with dichloromethane (3 × 15 mL), and the combined organic phases
were dried (Na2SO4) and concentrated. Chromatography (1% Et3N, 30%
EtOAc/hexane) afforded 0.9 g (90%) of a white solid: mp 121-122
°C; [R]20D +56.5 (c 0.69, CHCl3); IR (neat) 3331, 2951 cm-1; 1H NMR
(CDCl3) δ 0.85 (t, J ) 7.3 Hz, 6 H), 0.94 (t, J ) 7.6 Hz, 3 H), 1.12
(m, 1 H), 1.28-1.85 (m, 16 H), 1.91 (b, 1 H), 3.03 (m, 1 H), 3.47 (dd,
1
cm-1; H NMR (CDCl3) δ 0.86 (t, J ) 7.2 Hz, 3 H), 0.89 (t, J ) 7.3
Hz, 3 H), 0.93 (t, J ) 7.4 Hz, 3 H), 1.29-1.68 (m, 9 H), 1.71 (dd, J
) 1.4, 6.4 Hz, 3 H), 2.12 (m, 2 H), 2.63 (m, 1 H), 3.00 (dd, J ) 8.6,
10.3 Hz, 1 H), 5.43 (m, 1 H), 5.62 (dq, J ) 6.4, 15.4 Hz, 1 H); 13C
NMR δ (CDCl3) 12.1, 12.3, 14.2, 17.7, 17.8, 18.5, 18.7, 36.4, 57.6,
57.7, 60.6, 65.2, 128.7, 132.5, 211.1; HRMS calcd for C15H27NO (M
+ H) 238.2171, found 238.2163.
(2R,3R,5R,6R)-(-)-3,5-Diethyl-2-((E)-prop-1-enyl)-6-propylpip-
eridin-4-one (27). Second to elute, 0.5 g (18% from (-)-18) of a
colorless oil; [R]20D -57.6 (c 1.06, CHCl3); IR (neat) 3334, 2960, 1704
1
cm-1; H NMR (CDCl3) δ 0.86 (t, J ) 7.2 Hz, 3 H), 0.87 (t, J ) 7.3
Hz, 3 H), 0.91 (t, J ) 7.1 Hz, 3 H), 1.24-1.67 (m, 8 H), 1.69 (dd, J
9
8406 J. AM. CHEM. SOC. VOL. 127, NO. 23, 2005